NONMEM Users Network Archive

Hosted by Cognigen

Post-doctoral Fellowship opening

From: Gaurav Bajaj <gaurav.bajaj>
Date: Wed, 14 Dec 2011 15:15:49 -0500

Dear All,

There is an opening for a postdoctoral fellowship at The Children's
Hospital of Philadelphia. Please see the following message from Dr. Chee

The Children Hospital of Philadelphia is offering a postdoctoral fellowship
position in clinical pharmacology and pharmacometrics. This fellowship is
focused on the application of
pharmacokinetic/pharmacodynamic/pharmacogenetic and disease modeling and
simulation to facilitate the drug development in industry and improve
patient care in academic setting. Fellow has the opportunity to gain a
breadth of experience including: population pharmacokinetic and mechanistic
modeling of the biotechnology drugs; population
pharmacokinetic/pharmacodynamic/pharmacogenetic modeling of analgesia drugs
in pediatric patients from NIH-funded study; population
pharmacokinetic/pharmacogenetics and compliance modeling of antiviral
therapy in HIV-infected subjects from NIH-funded study; and others. The
fellow is also has an option to involve in the development and evaluation
of the advanced numerical and computation methods for population data

An ideal candidate will have a doctoral degree (PhD, PharmD) in
pharmaceutical science, biology, engineering, pharmacy or other related
field and have experience or familiarity with mathematical modeling, such
as NONMEM, MATLAB, R, or any other applicable software.

Interested applicants can apply by referencing posting #11-25142 to
forward a CV and contact information for references to the following:

Chee M Ng, PharmD, PhD, FCP

Clinical Pharmacology and Therapeutics

Director, NVIDIA CUDA Research Center for Drug Development

Research Assistant Professor

Department of Pediatrics, School of Medicine

University of Pennsylvania

3501 Civic Center Blvd, CTRB Room 4010

Philadelphia, PA 19104

Tel: 267-4262826



Received on Wed Dec 14 2011 - 15:15:49 EST

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: